![Frontiers | Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins Frontiers | Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins](https://www.frontiersin.org/files/Articles/292641/fimmu-08-01347-HTML/image_m/fimmu-08-01347-g001.jpg)
Frontiers | Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins
![Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation](http://www.scielo.org.za/img/revistas/samj/v109n10/08f02.jpg)
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation
![IJMS | Free Full-Text | Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma IJMS | Free Full-Text | Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma](https://www.mdpi.com/ijms/ijms-20-02822/article_deploy/html/images/ijms-20-02822-g001.png)
IJMS | Free Full-Text | Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
![Vincent Rajkumar on Twitter: "Monoclonal Gammopathy of Undetermined Significance (MGUS). Present in ~5% of all people age 50+ Therefore something all clinicians should know about. Brief summary. #medtwitter @ESHaematology 1/ https://t.co/VyhxekBiTe" / Vincent Rajkumar on Twitter: "Monoclonal Gammopathy of Undetermined Significance (MGUS). Present in ~5% of all people age 50+ Therefore something all clinicians should know about. Brief summary. #medtwitter @ESHaematology 1/ https://t.co/VyhxekBiTe" /](https://pbs.twimg.com/media/FezN_cJUYAAh0co.jpg)
Vincent Rajkumar on Twitter: "Monoclonal Gammopathy of Undetermined Significance (MGUS). Present in ~5% of all people age 50+ Therefore something all clinicians should know about. Brief summary. #medtwitter @ESHaematology 1/ https://t.co/VyhxekBiTe" /
![Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All](https://www.mdpi.com/cancers/cancers-12-01554/article_deploy/html/images/cancers-12-01554-g001.png)
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
![Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b2a65811-cfaf-47ad-bce2-3b05b6fb1454/bjh_6235_f1.gif)
Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library
![Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_JFP_06407_ArticleW1_t2.jpg.jpg)
Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine
![Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11914-018-0479-z/MediaObjects/11914_2018_479_Fig1_HTML.png)